Business Opportunities

Intas Pharma ties up with US company

Ahmedabad-based Intas Pharmaceuticals Ltd (Intas) has entered into a strategic partnership with US biotechnology company Amarillo Biosciences, Inc (ABI), whereby Intas will sponsor clinical trials of ABI’s orally administered interferon-alpha lozenges for influenza, which could also be used in combating the H1N1 virus. Sensex ends up 35pts According to recent reports, the death rate in India from H1N1 infection is 3.1 per cent and the virus continues to circulate in the country.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
No takers for gold sold by banks
Investors, who bought gold from banks, are in a fix as leading jewellery houses are not ready to buy it and it cannot be sold back to banks either.
Popular Articles

BSNL getting MNP network ready to lure mobile users of rivals
In a bid to attract subscribers of rival companies, state-run telecom operator Bharat Sanchar Nigam (BSNL) is gearing up to start mobile number portability (MNP) services as soon as telecom regulator Trai issues tariff structure.

Production deals shouldn't be tweaked by anyone: RIL
Energy major Reliance Industries today said that Production Sharing Contracts (PSCs), like the one it had signed for KG-D6 fields with the government, should not be tampered with by anyone.